MedAI Verdict
All comparisons

KATE vs PaceMate

Three PubMed papers carry Mednition-employed authors, among them a 2025 descriptive study of pre-eclampsia identification at triage. KATE Sepsis has held an FDA Breakthrough Device Designation since November 2023, and openFDA holds no 510(k) record for either vendor.

PaceMate sells to device clinics, a separate purchase from an ED's. It states ISO/IEC 27001:2022, HITRUST r2, SOC 2 Type 2, SOC 3 and HIPAA with a BAA available, hosted on AWS, and lists Epic, Oracle Health and athenahealth as bi-directional. Auto-Triage ranks device alerts by clinical priority, and the vendor claims a 61% drop in physician alert burden and 73% fewer loop recorder false-positive alerts. PubMed shows ten PaceMate-affiliated papers, none with the product in the title. The vendor says 39 peer-reviewed studies.

Decision support · Reviewed November 2, 2026

KATE logo

KATE

by Mednition · founded 2014

KATE AI recommends emergency department triage acuity and flags sepsis risk from EHR data at triage.

PaceMate logo

PaceMate

by PaceMate

Cardiac device remote monitoring platform whose Auto-Triage ranks device alerts by clinical priority for device clinics.

When to pick each one

KATE

  • Aimed at emergency department triage and sepsis
  • Adventist Health White Memorial named as customer
Read the full KATE review

PaceMate

  • Auto-Triage ranks device alerts by clinical priority
  • Bi-directional Epic, Oracle Health and athenahealth
  • ISO 27001, HITRUST r2 and SOC 2 Type 2
Read the full PaceMate review

Score

Each row shows points earned of points available under the published rubric.

KATE

12of 100

Tracked

PaceMate

47of 100

Solid choice
Score by dimension for KATE and PaceMate
DimensionKATEPaceMateDifference
FDA clearance0 / 120 / 120
HIPAA / SOC2 / BAA0 / 1010 / 10-10
EHR integrations (count)0 / 5.61.7 / 5.6-1.7
Top-3 EHR coverage (Epic / Oracle / Athena)0 / 4.84.8 / 4.8-4.8
Bidirectional write-back0 / 1.20 / 1.20
Peer-reviewed papers0 / 2114.7 / 21-14.7
RCT / meta-analysis / systematic review0 / 94.5 / 9-4.5
Funding & adoption signal3 / 123 / 120
Pricing transparency1.3 / 2.51.3 / 2.50
Years in market6 / 60 / 6+6

Scroll horizontally to see every column.

How scores are computed

Pricing

KATE

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price.

PaceMate

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price.

Evidence

KATE

FDA decisions

No FDA decision cited in our research as of November 2, 2026.

Compliance and integrations

Documented from each vendor’s own pages.

SpecKATEPaceMate
Free tierNo / unverifiedNo / unverified
HIPAANo / unverifiedYes
SOC 2 Type IINo / unverifiedYes
EHR integrationsNot specifiedEpic, Oracle Health, athenahealth
Founded2014n/a
HQUSn/a

Scroll horizontally to see both columns.

Common questions

Open the full decision support comparison

Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.